Publications by authors named "Kelly Colletti"

Claim this Profile
T
Technical Considerations of Pharmacokinetic Assays for LNP-mRNA Drug Products by RT-qPCR.
Jason Pennucci, Amanda Hays, Wendy Adamowicz, Mitra Azadeh, Mohamed Benhammadi, Kelly Colletti

AAPS J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development.
Amanda Hays, Mark Wissel, Kelly Colletti, Russell Soon, Mitra Azadeh

AAPS J· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations on qPCR/ddPCR assay validation by GCC.
Mark Wissel, Martin Poirier, Christina Satterwhite, John Lin, Rafiq Islam, Kelly Colletti

Bioanalysis· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations on ELISpot assay validation by the GCC.
Rafiq Islam, Jennifer Vance, Martin Poirier, Jennifer Zimmer, Ardeshir Khadang, Kelly Colletti

Bioanalysis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying context of use to quantitative polymerase chain reaction method validation and analysis: a recommendation from the European Bioanalysis Forum.
Anna Laurén, Manuela Braun, Paul Byrne, Chiara Cazzin, Kelly Colletti

Bioanalysis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioanalytical challenges and unique considerations to support pharmacokinetic characterization of bispecific biotherapeutics.
Mark Ma, Kelly Colletti, Tong-Yuan Yang, Sheldon Leung, Susan Pederson

Bioanalysis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
11th GCC Closed Forum: cumulative stability; matrix stability; immunogenicity assays; laboratory manuals; biosimilars; chiral methods; hybrid LBA/LCMS assays; fit-for-purpose validation; China Food and Drug Administration bioanalytical method validation.
Rafiq Islam, Chad Briscoe, Joseph Bower, Stephanie Cape, Mark Arnold, Kelly Colletti

Bioanalysis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conference Report: Bioanalysis-related topics presented at the International Conference and Exhibition on Biowaivers and Biosimilars.
Kelly S Colletti

Bioanalysis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of human cytomegalovirus UL84 virus- and cell-encoded binding partners by using proteomics analysis.
Yang Gao, Kelly Colletti, Gregory S Pari

J Virol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overexpression of the kaposi's sarcoma-associated herpesvirus transactivator K-Rta can complement a K-bZIP deletion BACmid and yields an enhanced growth phenotype.
Taeko Kato-Noah, Yiyang Xu, Cyprian C Rossetto, Kelly Colletti, Iva Papousková

J Virol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human cytomegalovirus UL84 interacts with an RNA stem-loop sequence found within the RNA/DNA hybrid region of oriLyt.
Kelly S Colletti, Kate E Smallenburg, Yiyang Xu, Gregory S Pari

J Virol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human cytomegalovirus UL84 is a phosphoprotein that exhibits UTPase activity and is a putative member of the DExD/H box family of proteins.
Kelly S Colletti, Yiyang Xu, Irena Yamboliev, Gregory S Pari

J Biol Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human cytomegalovirus DNA replication requires transcriptional activation via an IE2- and UL84-responsive bidirectional promoter element within oriLyt.
Yiyang Xu, Sylvia A Cei, Alicia Rodriguez Huete, Kelly S Colletti, Gregory S Pari

J Virol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human cytomegalovirus UL84 oligomerization and heterodimerization domains act as transdominant inhibitors of oriLyt-dependent DNA replication: evidence that IE2-UL84 and UL84-UL84 interactions are required for lytic DNA replication.
Kelly S Colletti, Yiyang Xu, Sylvia A Cei, Margaret Tarrant, Gregory S Pari

J Virol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP).
David P AuCoin, Kelly S Colletti, Sylvia A Cei, Iva Papousková, Margaret Tarrant

Virology· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human cytomegalovirus UL84 localizes to the cell nucleus via a nuclear localization signal and is a component of viral replication compartments.
Yiyang Xu, Kelly S Colletti, Gregory S Pari

J Virol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replication.
David P AuCoin, Kelly S Colletti, Yiyang Xu, Sylvia A Cei, Gregory S Pari

J Virol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis